15Mar 2025
Medications and Gingival Disorders: Insights from USFDA Adverse Reports

Medications and Gingival Disorders: Insights from USFDA Adverse Reports

Certain medications are significantly linked to gingival disorders, as revealed by USFDA AERS data (2004–2024). Among 11,465 reports, anti-osteoporotic drugs, anti-thrombotics, calcium channel blockers, and immunosuppressants were strongly associated with gum issues. Phenytoin was linked to hypertrophy and bleeding, while finasteride, COVID-19 vaccines, and levothyroxine emerged as new signals. Increased awareness and interdisciplinary management are crucial for mitigating drug-induced oral health effects.

  • #dentistry

Like

Save

Share